Evidence map›Paper›PMID 35410376›Full record

SynthesisNature genetics2022

Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia.

Duncan S Palmer, Daniel P Howrigan, Sinéad B Chapman, Rolf Adolfsson, Nick Bass, Douglas Blackwood, Marco P M Boks, Chia-Yen Chen, Claire Churchhouse, Aiden P Corvin and 37 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 4 pooled it
35.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 4 syntheses or guidelines pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 6 countries.

Duncan S PalmerAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. duncan.stuart.palmer@gmail.com.ORCID http://orcid.org/0000-0002-0824-0047
Daniel P HowriganAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7721-4838
Sinéad B ChapmanStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9454-2737
Rolf AdolfssonDepartment of Clinical Sciences, Psychiatry, Umea University, Umea, Sweden.
Nick BassDivision of Psychiatry, University College London, London, UK.
Douglas BlackwoodDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-4076-9346
Marco P M BoksDepartment of Psychiatry, Brain Center UMC Utrecht, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0001-6163-7484
Chia-Yen ChenAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9548-5597
Claire ChurchhouseAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Aiden P CorvinTrinity College Dublin, Dublin, Ireland.
Nicholas CraddockMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
David CurtisUCL Genetics Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-4089-9183
Arianna Di FlorioDivision of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
Faith DickersonSheppard Pratt, Baltimore, MD, USA.
Nelson B FreimerDepartment of Psychiatry and Biobehavioral Science, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-3586-6587
Fernando S GoesDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6262-8264
Xiaoming JiaWeill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Ian JonesMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0001-5821-5889
Lisa JonesDepartment of Psychological Medicine, University of Worcester, Worcester, UK.ORCID http://orcid.org/0000-0002-5122-8334
Lina JonssonDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Rene S KahnDivision of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-5909-8004
Mikael LandénDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-4496-6451
Adam E LockeDivision of Genomics & Bioinformatics and McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-6227-198X
Andrew M McIntoshDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-0198-4588
Andrew McQuillinDivision of Psychiatry, University College London, London, UK.ORCID http://orcid.org/0000-0003-1567-2240
Derek W MorrisCentre for Neuroimaging, Cognition and Genomics, Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland.ORCID http://orcid.org/0000-0002-3413-570X
Michael C O'DonovanMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0001-7073-2379
Roel A OphoffDepartment of Psychiatry and Biobehavioral Science, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8287-6457
Michael J OwenMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0003-4798-0862
Nancy L PedersenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Danielle PosthumaDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0001-7582-2365
Andreas ReifDepartment of Psychiatry, Psychosomatic Medicine and Psychiatry, University Hospital Frankfurt - Goethe University, Frankfurt, Germany.ORCID http://orcid.org/0000-0002-0992-634X
Neil RischInstitute for Human Genetics, University of California, San Francisco, San Francisco, CA, USA.
Catherine SchaeferDivision of Research, Kaiser Permanente Northern California, Oakland, CA, USA.ORCID http://orcid.org/0000-0003-2644-055X
Laura ScottDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-4886-5084
Tarjinder SinghAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0601-6815
Jordan W SmollerPsychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0381-6334
Matthew SolomonsonProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
David St ClairInstitute for Medical Sciences, University of Aberdeen, Aberdeen, UK.
Eli A StahlDivision of Psychiatric Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Annabel VreekerDepartment of Child and Adolescent Psychiatry/Psychology, Erasmus MC Sophia Children Hospital, Erasmus University, Rotterdam, the Netherlands.
James T R WaltersMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0002-6980-4053
Weiqing WangDivision of Psychiatric Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-1565-0148
Nicholas A WattsAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Robert YolkenStanley Division of Developmental Neurovirology, Johns Hopkins University, Baltimore, MD, USA.
Peter P ZandiDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-8423-2623
Benjamin M NealeAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. bneale@broadinstitute.org.ORCID http://orcid.org/0000-0003-1513-6077
Broad Institute · USCardiff University · GBIcahn School of Medicine at Mount Sinai · USJohns Hopkins University · USKaiser Permanente · USKarolinska Institutet · SEUniversity College London · GBUniversity of California, Los Angeles · USUniversity of Edinburgh · GBAmsterdam Neuroscience · NLCentre for Mental Health · GBErasmus MC - Sophia Children’s Hospital · NLGoethe University Frankfurt · DEHarvard University · USJames S. McDonnell Foundation · USOllscoil na Gaillimhe – University of Galway · IEQueen Mary University of London · GBSheppard and Enoch Pratt Hospital · USTrinity College Dublin · IEUmeå University · SE

Funding

A Resource for Genetic Epidemiology Research in Adult Health and AgingRC2AG036607 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI RISCH, NEIL J., SCHAEFER, CATHERINE ANN · 2009 to 2010
$24.8M
Multi-Ethnic Genome-Wide Study of Bipolar DisorderR01MH085543 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI SCHAEFER, CATHERINE ANN · 2008 to 2012
$12.4M
International Cohort Collection for Bipolar DisorderR01MH085542 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SMOLLER, JORDAN W · 2008 to 2012
$10.7M
1/2 Genomic Strategies to Identify High-impact Psychiatric Risk VariantsU01MH105578 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B., GESCHWIND, DANIEL H · 2014 to 2018
$8.5M
Statistical methods to localize disease heritability and identify biological mechanismsR37MH107649 · NIMH · BROAD INSTITUTE, INC. · PI Benjamin Michael Neale · 2019 to 2026
$7.0M
Genomic Studies of Bipolar Disorder in a Large Cohort from The NetherlandsR01MH090553 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OPHOFF, ROEL A · 2010 to 2014
$6.0M
2/2 Large-Scale Genetic Studies of Schizophrenia in SwedenR01MH095034 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI STAHL, ELI A · 2012 to 2019
$3.6M
Quantifying and Characterizing the shared genetic contribution to common cancersU01CA194393 · NCI · UNIVERSITY OF WASHINGTON · PI KRAFT, PETER, LINDSTROEM, SARA · 2015 to 2023
$3.0M
The Bipolar Sequencing Consortium for Combined Analyses and Follow-Up - SupplementR01MH110437 · NIMH · JOHNS HOPKINS UNIVERSITY · PI BOEHNKE, MICHAEL L, FREIMER, NELSON B. · 2016 to 2018
$2.5M
Statistical Methods for the Design and Interpretation of Deep Resequencing StudieR01MH084676 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI SUNYAEV, SHAMIL · 2008 to 2010
$1.7M
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancerR01CA194393 · NCI · UNIVERSITY OF WASHINGTON · PI KRAFT, PETER, LINDSTROEM, SARA · 2020 to 2022
$1.6M
Medical Research Council G1000708Medical Research Council MR/L010305/1Medical Research Council MR/P005748/1NCI NIH HHS R01 CA194393NCI NIH HHS U01 CA194393NIA NIH HHS RC2 AG036607NIMH NIH HHS R01 MH084676NIMH NIH HHS R01 MH085542NIMH NIH HHS R01 MH085543NIMH NIH HHS R01 MH090553NIMH NIH HHS R01 MH095034NIMH NIH HHS R01 MH110437NIMH NIH HHS R37 MH107649NIMH NIH HHS U01 MH105578
6 · The paper itself

Abstract

We report results from the Bipolar Exome (BipEx) collaboration analysis of whole-exome sequencing of 13,933 patients with bipolar disorder (BD) matched with 14,422 controls. We find an excess of ultra-rare protein-truncating variants (PTVs) in patients with BD among genes under strong evolutionary constraint in both major BD subtypes. We find enrichment of ultra-rare PTVs within genes implicated from a recent schizophrenia exome meta-analysis (SCHEMA; 24,248 cases and 97,322 controls) and among binding targets of CHD8. Genes implicated from genome-wide association studies (GWASs) of BD, however, are not significantly enriched for ultra-rare PTVs. Combining gene-level results with SCHEMA, AKAP11 emerges as a definitive risk gene (odds ratio (OR) = 7.06, P = 2.83 × 10

Indexed as

Bipolar DisorderSchizophreniaA Kinase Anchor ProteinsExomeExome SequencingGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansAKAP11 protein, humanA Kinase Anchor Proteins

Identifiers

PMID35410376
PMCPMC9117467
OpenAlexW4223536896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.